Use and Safety of Anthroposophic Medications for Acute Respiratory and Ear Infections: A Prospective Cohort Study

Objective Anthroposophic medications (AMED) are widely used, but safety data on AMED from large prospective studies are sparse. The objective of this analysis was to determine the frequency of adverse drug reactions (ADR) to AMED in outpatients using AMED for acute respiratory and ear infections. Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Harald J. Hamre (Author), Anja Glockmann (Author), Michael Fischer (Author), David S. Riley (Author), Erik Baars (Author), Helmut Kiene (Author)
Format: Book
Published: AboutScience Srl, 2007-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9f4576ff0f194712a9d4fd87aa1d92e9
042 |a dc 
100 1 0 |a Harald J. Hamre  |e author 
700 1 0 |a Anja Glockmann  |e author 
700 1 0 |a Michael Fischer  |e author 
700 1 0 |a David S. Riley  |e author 
700 1 0 |a Erik Baars  |e author 
700 1 0 |a Helmut Kiene  |e author 
245 0 0 |a Use and Safety of Anthroposophic Medications for Acute Respiratory and Ear Infections: A Prospective Cohort Study 
260 |b AboutScience Srl,   |c 2007-01-01T00:00:00Z. 
500 |a 1177-3928 
500 |a 10.1177/117739280700200004 
520 |a Objective Anthroposophic medications (AMED) are widely used, but safety data on AMED from large prospective studies are sparse. The objective of this analysis was to determine the frequency of adverse drug reactions (ADR) to AMED in outpatients using AMED for acute respiratory and ear infections. Methods A prospective four-week observational cohort study was conducted in 21 primary care practices in Europe and the U.S.A. The cohort comprised 715 consecutive outpatients aged ≥1 month, treated by anthroposophic physicians for acute otitis and respiratory infections. Physicians' prescription data and patient reports of adverse events were analyzed. Main outcome measures were use of AMED and ADR to AMED. Results Two patients had confirmed ADR to AMED: 1) swelling and redness at the injection site after subcutaneous injections of Prunus spinosa 5%, 2) sleeplessness after intake of Pneumodoron ® 2 liquid. These ADR lasted one and two days respectively; both subsided after dose reduction; none were unexpected; none were serious. The frequency of confirmed ADR to AMED was 0.61% (2/327) of all different AMED used, 0.28% (2/715) of patients, and 0.004% (3/73,443) of applications. Conclusion In this prospective study, anthroposophic medications used by primary care patients with acute respiratory or ear infections were well tolerated. Abbreviations A-: anthroposophy; ADR: adverse drug reactions; AE: adverse events; AM: anthroposophic medicine; AMED: AM medication; C-: conventional; ENE-patients: eligible, not enrolled patients; IIPCOS: International Primary Care Outcomes Study 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drug Target Insights, Vol 2 (2007) 
787 0 |n https://doi.org/10.1177/117739280700200004 
787 0 |n https://doaj.org/toc/1177-3928 
856 4 1 |u https://doaj.org/article/9f4576ff0f194712a9d4fd87aa1d92e9  |z Connect to this object online.